SPHS - ソフィリス・バイオ (Sophiris Bio Inc.)


   Momentum Strategies That Continue To Dominate Through January  2019-01-17
The 20 stocks in the Premium Portfolio from my membership service that draws from a wide range of different models in the financial literature has surged to 15% gains through January. These gains again appear to be primarily based on the strength of momentum and forensic negative stock selecti…
   Sophiris Bio Phase 2b Results Crushed On Data, But Is Still Pressing On  2018-12-19
Recently, Sophiris Bio ( SPHS ) announced results from its phase 2b study treating patients with prostate cancer using its drug topsalysin (PRX302). The study continued to do well in the most recent update, however, it was noted that adding a second dose did nothing to improve clinical…